Vaccine development against Schmallenberg virus: from classical inactivated to modified-live to scaffold particle vaccines. [PDF]
Wernike K +3 more
europepmc +1 more source
Acute Schmallenberg Virus Infections, France, 2012
Corinne Sailleau +9 more
doaj +1 more source
Serological screening in wild ruminants in Germany, 2021/2022: No evidence of SARS-CoV-2, bluetongue virus or pestivirus spread but high seroprevalences against Schmallenberg virus. [PDF]
Wernike K +13 more
europepmc +1 more source
Impacts of Schmallenberg virus infection in early lambing sheep flocks following the second wave of virus circulation in South West England in 2012/2013: a mixed-methods descriptive study. [PDF]
Glover M, Blake N, Phythian CJ.
europepmc +1 more source
Reemerging Schmallenberg Virus Infections, Germany, 2012
Franz J. Conraths +5 more
doaj +1 more source
Schmallenberg virus: Responding to the challenge
Roberts, Helen +2 more
openaire +2 more sources
Development, Characterization, and Validation of an MS2 Phage-Based Armored RNA Control for Schmallenberg Virus Detection. [PDF]
Zhao M +12 more
europepmc +1 more source
Seroprevalence and risk factors associated with bluetongue and Schmallenberg virus infections in domestic small ruminants in Türkiye. [PDF]
Ertarğın FF, Babaoglu AR, Ekin İH.
europepmc +1 more source
High genetic variability of Schmallenberg virus M-segment leads to efficient immune escape from neutralizing antibodies. [PDF]
Wernike K +11 more
europepmc +1 more source

